Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
---|
12/05/2002 | CA2448637A1 A pharmaceutical combination comprising either (s)-2-ethoxy-3 [4-(2- {4-methane sulfonyl oxyphenyl} ethoxy)phenyl] propanoic acid or 3-{4-[2- (4-tert-butoxy carbonylamino phenyl) ethoxy] phenyl}-(s)-2-ethoxy propanoic acid and insulin |
12/05/2002 | CA2448626A1 Carbamate and oxamide compounds as inhibitors of cytokine production |
12/05/2002 | CA2448562A1 Metallotetrapyrrolic photosensitizing agents for use in photodynamic therapy |
12/05/2002 | CA2448348A1 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
12/05/2002 | CA2448320A1 Ribozyme based treatment of female reproductive diseases |
12/05/2002 | CA2448306A1 Method for treating fibrotic diseases or other indications |
12/05/2002 | CA2448305A1 2-anilino-pyrimidine derivatives as cyclin dependent kinase inhibitors |
12/05/2002 | CA2448294A1 Method for treating fibrotic diseases or other indications vi |
12/05/2002 | CA2448248A1 Pharmaceutical composition comprising a tricyclic compound for the prevention or treatment of skin diseases |
12/05/2002 | CA2448205A1 Oxazol/thiazol-derivatives activators of the hppar-alpha receptor |
12/05/2002 | CA2448198A1 5-substituted-2-arylpyridines as crf1 modulators |
12/05/2002 | CA2448148A1 Carbohydrate-associated proteins |
12/05/2002 | CA2448146A1 Secreted proteins |
12/05/2002 | CA2448109A1 Alternative splice forms of proteins as basis for multiple therapeutic modalities |
12/05/2002 | CA2448103A1 Thiazole or oxazole derivatives which are useful in the treatment of cardiovascular and related diseases |
12/05/2002 | CA2448101A1 Process for preparing a thialzole ppar-ligand and polymorphs thereof |
12/05/2002 | CA2448062A1 Single amino acid based compounds for counteracting effects of reactive oxygen species and free radicals |
12/05/2002 | CA2448023A1 Carboxamide-substituted phenylurea derivatives and method for production thereof as medicaments |
12/05/2002 | CA2447879A1 Attractin/mahogany-like polypeptides, polynucleotides, antibodies and methods of use thereof |
12/05/2002 | CA2447662A1 Transporters and ion channels |
12/05/2002 | CA2447657A1 Use of compositions comprising cyclooxygenase-2 selective inhibitors in combination with radiation for inhibition or prevention of cardiovascular disease |
12/05/2002 | CA2447648A1 Pharmaceutical combinations |
12/05/2002 | CA2447475A1 Hydantion derivatives as inhibitors of matrix metalloproteinases |
12/05/2002 | CA2443713A1 Proteins associated with cell growth, differentiation, and death |
12/05/2002 | CA2411907A1 Preparation with vascular protective and anti-oxidative effect and use thereof |
12/05/2002 | CA2411549A1 Ligands of integrin receptors |
12/04/2002 | EP1262546A1 Novel scavenger receptors |
12/04/2002 | EP1262490A1 GPib-LIPID BOND CONSTRUCT AND USE THEREOF |
12/04/2002 | EP1262200A2 Inhibition of platelet adherence and aggregation |
12/04/2002 | EP1262195A1 Vasoactive agents |
12/04/2002 | EP1262189A1 Leptin-resistance ameliorating agents |
12/04/2002 | EP1262184A1 Compositions comprising S-tofisopam and use of these compositions for the preparation of a medicament for the treatment or prevention of convulsions or seizures |
12/04/2002 | EP1262182A2 Methods and compositions for treating hypertension, angina and other disorders using optically pure(-) amlodipine |
12/04/2002 | EP1262176A1 Method of treating or inhibiting neutrophil chemotaxis by administering a mek inhibitor |
12/04/2002 | EP1262175A2 Use of renin-angiotensin antagonist for reducing post myocardial infarct mobidity and mortality |
12/04/2002 | EP1261744A2 Estrogen receptor beta variants and methods of detection thereof |
12/04/2002 | EP1261644A2 Modulation of the activity of the endothelial cell surface receptor ecrtp/dep-1 in the regulation of angiogenesis |
12/04/2002 | EP1261639A2 Chondromodulin-i related peptide |
12/04/2002 | EP1261638A2 Human fgf-23 gene and gene expression products |
12/04/2002 | EP1261636A2 Human protein kinases and protein kinase-like enzymes |
12/04/2002 | EP1261635A1 Human polynucleotides, polypeptides, and antibodies |
12/04/2002 | EP1261625A2 Memno peptides, a process for their preparation and their use |
12/04/2002 | EP1261609A1 Triazolotriazinones and the use thereof |
12/04/2002 | EP1261606A1 Substituted oxazolidinones and their use in the field of blood coagulation |
12/04/2002 | EP1261605A1 Benzoxazole derivatives as tnf and pde iv inhibitors |
12/04/2002 | EP1261604A1 Compounds having antitumor activity: process for their preparation and pharmaceutical compositions containing them |
12/04/2002 | EP1261601A1 Substituted indoles for modulating nfkb activity |
12/04/2002 | EP1261595A1 Arylpiperazines and arylpiperidines and their use as metalloproteinase inhibiting agents |
12/04/2002 | EP1261594A1 5,10-dihydroacridines as calcium channel blockers |
12/04/2002 | EP1261590A1 Piperidine- and piperazine substituted n-hydroxyformamides as inhibitors of metalloproteinases |
12/04/2002 | EP1261589A1 Imidazole compounds and their use as adenosine deaminase inhibitors |
12/04/2002 | EP1261588A1 New imidazole derivatives |
12/04/2002 | EP1261586A2 Cyclopropyl-fused pyrrolidine-based inhibitors of dipeptidyl peptidase iv, processes for their preparation, and their use |
12/04/2002 | EP1261585A1 Substituted indole mannich bases |
12/04/2002 | EP1261583A1 INHIBITORS OF THE ICE/Ced-3 FAMILY OF CYSTEINE PROTEASES |
12/04/2002 | EP1261379A2 Genetic modification of the lung as a portal for gene delivery |
12/04/2002 | EP1261373A2 Composition for the treatment diabetes mellitus containing an insuline sensitizer and agent used in the treatment of cardiac conditions |
12/04/2002 | EP1261364A1 Method of treating or inhibiting cellular injury or cell death |
12/04/2002 | EP1261349A1 Compounds with chelation affinity and selectivity for first transition series elements and their use |
12/04/2002 | EP1261346A1 Modulation of cardiovascular injury |
12/04/2002 | EP1261337A2 Compositions and methods for the treatment of inflammatory diseases using topoisomerase inhibitors |
12/04/2002 | EP1261336A2 Il-8 receptor antagonists |
12/04/2002 | EP1261330A2 Method for increasing intestinal absorption of fat soluble vitamins in post-menopausal women and in lower animals |
12/04/2002 | EP1261329A2 Il-8 receptor antagonists |
12/04/2002 | EP1261328A1 Il-8 receptor antagonists |
12/04/2002 | EP1261327A2 Adenosine receptor modulators |
12/04/2002 | EP1180026B1 Use of 15-deoxyspergualin for the treatment of hyperreactive inflammatory diseases and autoimmune diseases |
12/04/2002 | EP1143805B1 Method for reducing incidence of ascites in poultry by aid of natamycin |
12/04/2002 | EP1131304B1 N- 4-(3-chloro-4-fluoro-phenylamino)-7-(3-morpholin-4-yl-propoxy)-quinazolin-6-yl]-acrylamide, an irreversible inhibitor of tyrosine kinases |
12/04/2002 | EP1097139B1 Quinoline derivatives |
12/04/2002 | EP1058683B1 Farnesyl transferase inhibitors having a piperidine structure and process for preparation thereof |
12/04/2002 | EP0971961B1 N-sulphated hyaluronic acid compounds, derivatives thereof and a process for their preparation |
12/04/2002 | EP0971882B1 Nitro-benzamide useful as anti-arrhythmic agent |
12/04/2002 | EP0928291B1 3-mercaptoacetylamino-1,5-substituted-2-oxo-azepan derivatives useful as inhibitors of matrix metalloproteinase |
12/04/2002 | CN1383427A Process for preparing N6-substituted deaza-adenosine derivatives |
12/04/2002 | CN1382682A 2-(alpha-hydroxypentyl) benzoate and its preparing process and usage |
12/04/2002 | CN1382484A Corn tassel injection and its preparing process |
12/04/2002 | CN1382483A Hypoglycemic and antihypertensive medicine prepared from edible plant tissue and its preparing process and usage |
12/04/2002 | CN1382479A External-applied Chinese medicine for treating hypertension and its preparing process |
12/04/2002 | CN1382471A Instant particles 'Tongmaihuonao' for invigorating pulse beat and promoting circulation of cerebral blood |
12/04/2002 | CN1382465A 'Wugu' recovery ointment |
12/04/2002 | CN1382463A Chinese-medicinal capsule for treating cardiovascular and cerebrovascular diseases |
12/04/2002 | CN1382446A Application of Funaosu in preventing and treating cadiovascular and cerebrovascular diseases |
12/04/2002 | CN1095375C Medicated cosmetics capable of treating primary and secondary varicose vein simultaneously and its prepn. method |
12/04/2002 | CN1095373C Medicine for preventing and treating hypotension, angiocardiopathy and cerebrovascular disease |
12/04/2002 | CA2384907A1 Methods and compositions relating to mek5 and cardiac hypertrophy and dilated cardiomyopathy |
12/03/2002 | WO2001096365A1 Pyridine-2-yl-aminoalkyl carbonyl glycyl-$g(b)-alanine and derivatives thereof |
12/03/2002 | US6489514 (-)-Secoisolariciresinol as an antioxidant obtained from a new natural source namely stereospermum personatum |
12/03/2002 | US6489478 4-amino substituted-2-substituted-1,2,3,4-tetrahydroquinolines |
12/03/2002 | US6489476 Fructose-1,6-bisphosphatase enzyme inhibitors are useful in the treatment of diabetes and other conditions associated with elevated blood glucose or excess glycogen storage. |
12/03/2002 | US6489475 Method of producing heterocyclic derivatives |
12/03/2002 | US6489473 Pyrroloazepine derivatives |
12/03/2002 | US6489366 Combinations of cholesteryl ester transfer protein inhibitors and nicotinic acid derivatives for cardiovascular indications |
12/03/2002 | US6489363 For therapy of sleepiness, tiredness, parkinson's disease, cerebral ischemia, stroke, sleep apneas, eating disorders, attention deficit hyperactivity disorder, cognitive dysfunction or fatigue, stimulation of appetite |
12/03/2002 | US6489362 Suitable for use with all young meat-type chickens where the desired effect is a decrease in the incidence of ascites; in feed or water supply |
12/03/2002 | US6489353 Antiinflammatory agents; autoimmune diseases; central nervous system disorders |
12/03/2002 | US6489352 Antiepileptic agents; nervous system disorders |
12/03/2002 | US6489344 For treatment diabetes in a human or animal subject |
12/03/2002 | US6489333 Heterocyclic compounds containing a guanidine mimic, for inhibition of cell adhesion, treatment of angiogenesis disorders, inflammation, cancer metastasis, diabetic retinopathy, thrombosis, restenosis, macular degeneration |
12/03/2002 | US6489332 A1 adenosine receptor antagonists |